☆ 4.5 Article

Allergy to low dose sugammadex

ANAESTHESIA (2011)

Journal

ANAESTHESIA

Volume 66, Issue 3, Pages 217-219

Publisher

WILEY-BLACKWELL

DOI: 10.1111/j.1365-2044.2010.06611.x

Keywords

-

Categories

Anesthesiology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Abstract

We describe the case of a fit 17-year-old man who developed a severe allergic reaction to a low clinical dose of sugammadex (3.2 mg kg(-1), 200 mg intravenously), 1 min after its administration. This was manifest by an intense erythema over the anterior part of the thorax, severe lip and palpebral oedema and bilateral wheeze. On later investigation, the patient had a positive skin prick test to sugammadex (5-mm diameter response, with a negative saline control and positive histamine control of 5 mm) and no response to any other drug tested. Other diagnostic tests supported a diagnosis of allergic reaction to sugammadex.

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Article Allergy

Single low-dose exposure to cow's milk at diagnosis accelerates cow's milk allergic infants' progress on a milk ladder programme

Yvonne M. d'Art, Lisa Forristal, Aideen M. Byrne, John Fitzsimons, Ronald van Ree, Audrey DunnGalvin, Jonathan O'Brien Hourihane

Summary: The study shows that introducing baked milk after the diagnosis of cow's milk allergy can safely and effectively improve infants' tolerance to milk. Maternal anxiety is also found to be associated with infants' progress on the milk ladder.

ALLERGY (2022)

Add to Collection

Article Allergy

In-Office Amoxicillin to Increase Graded-Dose Challenges at Initial Evaluation for Penicillin Allergy

Margaret Redmond, Rebecca Scherzer, Charles Hardy, Charlie Macias, Julie Samora, David Stukus

Summary: The study aimed to increase the percentage of low-risk pediatric patients with a penicillin allergy history who underwent same-day amoxicillin graded-dose challenges (GDCs) in the outpatient allergy clinic, and to sustain it for 6 months. By providing the medication and adjusting the appointment schedule, the percentage of patients completing GDCs significantly increased.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2023)

Add to Collection

Article Allergy

First-Dose mRNA COVID-19 Vaccine Allergic Reactions: Limited Role for Excipient Skin Testing

Anna R. Wolfson, Lacey B. Robinson, Lily Li, Aubree E. McMahon, Amelia S. Cogan, Xiaoqing Fu, Paige Wickner, Upeka Samarakoon, Rebecca R. Saff, Kimberly G. Blumenthal, Aleena Banerji

Summary: Most patients with reported allergic reactions to the first dose of mRNA COVID-19 vaccines can safely receive the second dose after excipient skin testing, even if the results are positive. Some patients may require antihistamine medication or even epinephrine treatment.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2021)

Add to Collection

Article Allergy

Safe egg yolk consumption after a negative result for low-dose egg oral food challenge

Noriyuki Yanagida, Sakura Sato, Kyohei Takahashi, Tomoyuki Asaumi, Ken-ichi Nagakura, Kiyotake Ogura, Nobue Takamatsu, Motohiro Ebisawa

Summary: Most children with egg allergies can safely consume egg yolk slightly contaminated with egg white after a negative result of low-dose egg oral food challenge, which may improve their quality of life by making egg yolk products available.

PEDIATRIC ALLERGY AND IMMUNOLOGY (2021)

Add to Collection

Article Allergy

Immunological effects of adjuvanted low-dose allergoid allergen-specific immunotherapy in experimental murine house dust mite allergy

Alexander Heldner, Francesca Alessandrini, Dennis Russkamp, Sonja Heine, Benjamin Schnautz, Adam Chaker, Juliet Mwange, Thalia L. Carreno Velazquez, Matthew D. Heath, Murray A. Skinner, Matthias F. Kramer, Ulrich M. Zissler, Carsten B. Schmidt-Weber, Simon Blank

Summary: This study demonstrated that low-dose allergoid AIT had comparable efficacy to suppress allergic airway inflammation and Th2-type cytokine secretion as high-dose extract AIT, but was less effective in inducing a potentially protective IgG1 response. Combining low-dose allergoid AIT with MCT or MCT and dose-adjusted MPL promoted Th1-inducing mechanisms and robust B-cell activation to counterbalance the allergic Th2 immune response. Conclusion: Low allergen doses induce cellular and humoral mechanisms counteracting Th2-driven inflammation by using allergoids and dose-adjusted adjuvants.

ALLERGY (2022)

Add to Collection

Article Environmental Sciences

Exposure to low-dose cadmium induces testicular ferroptosis

Lijuan Xiong, Bin Zhou, Jamie L. Young, Kupper Wintergerst, Lu Cai

Summary: Cadmium exposure can induce testicular damage through ferroptosis, possibly due to iron accumulation and decreased expression of Nrf2, HO-1, SOD2, and SLC7A11.

ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY (2022)

Add to Collection

Article Allergy

Cow's milk and egg protein threshold dose distributions in children tolerant to beef, baked milk, and baked egg

Rocco Luigi Valluzzi, Carla Riccardi, Stefania Arasi, Anna Lucia Piscitelli, Veronica Calandrelli, Lamia Dahdah, Vincenzo Fierro, Maurizio Mennini, Alessandro Fiocchi

Summary: This study aimed to verify the eliciting doses for milk and egg-allergic children who can tolerate baked food. The results showed that this subpopulation of allergic children displayed higher reactivity thresholds than the general population. This provides important information for individual and population risk assessment.

ALLERGY (2022)

Add to Collection

Article Allergy

Second-dose COVID-19 vaccines are well tolerated in patients with allergic reactions to the first dose-a single center experience

Viktoria Puxkandl, Theresa Bangerl, Kathrin Hanfstingl, Emmanuella Guenova, Wolfram Hoetzenecker, Sabine Altrichter

Summary: According to this retrospective study, additives in COVID-19 vaccines may contribute to allergic reactions. However, the study found that currently available COVID-19 vaccines have a low overall potential for allergies and can be safely administered in patients who have experienced allergic reactions to the first dose.

WORLD ALLERGY ORGANIZATION JOURNAL (2022)

Add to Collection

Article Medicine, General & Internal

Low-Dose Subcutaneous or Intravenous Monoclonal Antibody to Prevent Malaria

R. L. Wu, A. H. Idris, N. M. Berkowitz, M. Happe, M. R. Gaudinski, C. Buettner, L. Strom, S. F. Awan, L. S. A. Holman, F. Mendoza, I. J. Gordon, Z. Hu, A. Campos Chagas, L. T. Wang, L. Da Silva Pereira, J. R. Francica, N. K. Kisalu, B. J. Flynn, W. Shi, W-P Kong, S. O'Connell, S. H. Plummer, Allison Beck, A. McDermott, S. R. Narpala, L. Serebryannyy, M. Castro, R. Silva, M. Imam, I Pittman, S. P. Hickman, A. J. McDougal, A. E. Lukoskie, J. R. Murphy, J. G. Gall, K. Carlton, P. Morgan, E. Seo, J. A. Stein, S. Vazquez, S. Telscher, E. Capparelli, E. E. Coates, J. R. Mascola, J. E. Ledgerwood, L. K. Dropulic, R. A. Seder

Summary: This study evaluated the safety and pharmacokinetics of L9LS, a next-generation antimalarial monoclonal antibody, and demonstrated its protective efficacy against controlled human malaria infection. L9LS was found to provide protection without evident safety concerns.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Add to Collection

Editorial Material Immunology

Immediate Reactions After the First Dose of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Messenger RNA Vaccines Do Not Preclude Second-Dose Administration

Kristine Vanijcharoenkarn, Frances Eun-Hyung Lee, Lindsay Martin, Jennifer Shih, Mary Elizabeth Sexton, Merin Elizabeth Kuruvilla

Summary: Addressing immediate adverse events after the first dose of COVID-19 vaccines, especially allergic reactions, is crucial for effective diagnosis and management to combat the pandemic.

CLINICAL INFECTIOUS DISEASES (2021)

Add to Collection

Editorial Material Health Care Sciences & Services

Sugammadex in Emergency Situations

Cyrus Motamed

Summary: Sugammadex is used in various emergency situations, including emergency surgery and rapid sequence intubation. The trend of using sugammadex after rocuronium instead of succinylcholine is increasing. In other emergency situations, such as anaphylactic shock caused by rocuronium or when intubation or ventilation is not possible, priority should be given to maintaining ventilation and hemodynamic stability, according to the traditional guidelines. Prompt reversal of neuromuscular blockade should be done if necessary for resuming ventilation.

JOURNAL OF PERSONALIZED MEDICINE (2023)

Add to Collection

Article Anesthesiology

Earlier and lower dose administration of sugammadex A randomised placebo-controlled trial

Olivier Duranteau, Wendy Fernandez, Turgay Tuna, Edgard Engelman, Luc Van Obbergh, Ionut Tabolcea

Summary: There was no significant difference in recovery time between injecting sugammadex at TOF1 or TOF2, but different dosages resulted in varied outcomes, consistent with other studies.

EUROPEAN JOURNAL OF ANAESTHESIOLOGY (2021)

Add to Collection

Article Medicine, Research & Experimental

Comparison of Sugammadex Dose for Intraoperative Neuromonitoring in Thyroid Surgery: A Randomized Controlled Trial

Young J. Chai, Jung-Man Lee, Dongwook Won, Jiwon Lee, Jin-Young Hwang, Tae K. Kim, Jee-Eun Chang, Hyerim Kim, Hyo J. Yang, Seong-Won Min

Summary: The study compared the effects of 1 and 2 mg/kg of sugammadex on intraoperative bucking and neuromonitoring quality during thyroid surgery. The results showed that 1 mg/kg dose induced less bucking than 2 mg/kg while providing comparable neuromonitoring quality.

LARYNGOSCOPE (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Exploring low-dose radiotherapy to overcome radio-immunotherapy resistance

Juan Wang, Jingxin Zhang, Weitao Wen, Fei Wang, Meng Wu, Dawei Chen, Jinming Yu

Summary: Immune checkpoint inhibitors (ICIs) have greatly improved cancer treatment, but the response rates are still not satisfactory. Low-dose radiotherapy (LDRT) has been shown to enhance the efficacy of immunotherapy by activating anti-tumor immunity. This paper reviews the strategies and potential opportunities of using LDRT to overcome resistance to ICIs, as well as the history, mechanisms, and challenges associated with this form of treatment.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2023)

Add to Collection

Article Biochemistry & Molecular Biology

Detection of biological responses to low-dose radiation in humans

Masaru Yamaguchi, Yota Tatara, Eka Djatnika Nugraha, Dwi Ramadhani, Yuki Tamakuma, Yoshiaki Sato, Tomisato Miura, Masahiro Hosoda, Shinji Yoshinaga, Mukh Syaifudin, Ikuo Kashiwakura, Shinji Tokonami

Summary: This study conducted proteomic analysis and oxidative modification profiling on blood samples collected from residents in high-level natural background radiation area and normal-level area in Mamuju, Indonesia and found dose-dependent oxidative modifications in human serum albumin. This finding provides a possibility for developing a methodology to evaluate biological responses to low-dose radiation exposure.

FREE RADICAL BIOLOGY AND MEDICINE (2022)

Add to Collection

Article Allergy

Onset of Nut Allergy in a Pediatric Cohort: Clinical and Molecular Patterns in the AFRUSEN Study

M. D. Ibanez-Sandin, Rodriguez Del P. Rio, M. Alvarado, B. E. Garcia, T. Garriga-Baraut, M. Reche Frutos, C. Escudero, A. Ramirez Jimenez, L. Vila, E. M. Lasa, C. Blasco, E. Marchan-Martin, A. Martorell, S. Sanchez-Garcia, M. Rodriguez-Alvarez, S. Infante, Rodriguez V. Vazquez, J. M. Olaguibel, M. Labrador-Horrillo, T. Carrillo

Summary: This study aimed to characterize the onset of nut allergy in children in southern Europe. The results showed that the onset of nut allergy in children occurred around the age of 6, slightly later than reported in English-speaking countries. Walnut was found to be the main trigger, followed by peanut. 2S albumin storage proteins, particularly Jug r 1, were identified as the most relevant allergens.

JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY (2022)

Add to Collection

Article Allergy

Serum microRNAs Catalog Asthma Patients by Phenotype

M. Gil-Martinez, J. M. Rodrigo-Munoz, B. Sastre, J. A. Canas, R. Garcia-Latorre, N. Redondo, L. de la Fuente, P. Minguez, I Mahillo-Fernandez, J. Sastre, S. Quirce, M. L. Caballero, J. M. Olaguibel, V del Pozo

Summary: The aim of this study was to identify serum miRNAs that can phenotype asthma patients. Next-generation sequencing and RT-qPCR validation revealed that hsa-miR-26a-1-3p and hsa-miR-376a-3p were associated with eosinophilic and noneosinophilic asthma. Furthermore, the expression of these miRNAs was correlated with the pathogenesis of asthma.

JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY (2022)

Add to Collection

Editorial Material Allergy

Evaluation of Fractional Exhaled Nitric Oxide During SARS-CoV-2 Infection

D. Betancor, M. Valverde-Mongue, A. Gomez-Lopez, B. Barroso, L. Ruete, J. M. Olaguibel, J. Sastre

JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY (2022)

Add to Collection

Letter Allergy

Anxiety and body mass index affect asthma control: data from a prospective Spanish cohort

Leyre Baptista-Serna, Jose Manuel Rodrigo-Munoz, Pablo Minguez, Marcela Valverde-Monge, Ebymar Arismendi, Pilar Barranco, Blanca Barroso, Irina Bobolea, Jose Antonio Canas, Blanca Cardaba, Maria Jesus Cruz, Elena Curto, Javier Dominguez-Ortega, Raquel Garcia-Latorre, Francisco J. Gonzalez-Barcala, Carlos Martinez-Rivera, Joaquim Mullol, Xavier Munoz, Jose Maria Olaguibel, Cesar Picado, Vicente Plaza, Santiago Quirce, Manuel J. Rial, Beatriz Sastre, Lorena Soto, Antonio Valero, Victoria del Pozo, Joaquin Sastre

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2022)

Add to Collection

Article Allergy

Exacerbations Among Patients With Asthma Are Largely Dependent on the Presence of Multimorbidity

J. Dominguez-Ortega, JA. Luna-Porta, JM. Olaguibel, P. Barranco, E. Arismendi, B. Barroso, D. Betancor, I. Bobolea, ML. Caballero, B. Cardaba, MJ. Cruz, E. Curto, FJ. Gonzalez-Barcala, I. Losantos-Garcia, C. Martinez-Rivera, P. Mendez-Brea, J. Mullol, X. Munoz, C. Picado, V. Plaza, V. del Pozo, MJ. Rial, J. Sastre, L. Soto, A. Valero, M. Valverde-Monge, S. Quirce

Summary: This study investigated the comorbidities and predictors of asthma exacerbations and found significant associations with multimorbidity, asthma severity, poor asthma control, airflow obstruction, increased sputum eosinophils, and a high-T2 inflammatory pattern.

JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY (2023)

Add to Collection

Article Allergy

Improvement in Olfaction in Patients With CRSwNP and Severe Asthma Taking Anti-IgE and Anti-IL-5 Biologics: A Real-Life Study

B. Barroso, M. Valverde-Monge, I Alobid, J. M. Olaguibel, M. J. Rial, S. Quirce, E. Arismendi, P. Barranco, D. Betancor, I Bobolea, B. Cardaba, Cruz M. J. Carmona, E. Curto, J. Dominguez-Ortega, F. Gonzalez-Barcala, C. Martinez-Rivera, I Mahillo-Fernandez, X. Munoz, C. Picado, V Plaza, Rodrigo J. M. Munoz, L. Soto-Retes, A. Valero, V del Pozo, J. Mullol, J. Sastre

Summary: This real-world study found that biological treatments, including omalizumab, mepolizumab, reslizumab, and benralizumab, can improve olfaction in patients with severe asthma and associated CRSwNP. There were no significant differences in olfaction improvement between different biologic drugs, with factors such as atopy, steroid use, and polyp size influencing the improvement. The study also showed no differences in olfaction improvement between N-ERD and non-N-ERD groups.

JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY (2023)

Add to Collection

Review Allergy

Eosinophilia Induced by Blocking the IL-4/IL-13 Pathway: Potential Mechanisms and Clinical Outcomes

J. M. Olaguibel, J. Sastre, J. M. Rodriguez, V del Pozo

Summary: There are currently five biological drugs available for the treatment of severe asthma. These drugs primarily target specific pathways to alleviate inflammation. Dupilumab treatment may lead to eosinophilia in some cases, but it is usually temporary. Reports have shown that dupilumab may also be associated with eosinophil-related diseases. Therefore, the presence of eosinophilia should be carefully considered when choosing a treatment plan. In such cases, using anti-IL-5/IL-5R drugs may be more suitable. Additionally, close monitoring of blood eosinophil count and clinical progress is necessary when switching from anti-IL-5/IL-5R drugs to anti-IL-4/IL-13R drugs.

JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY (2022)

Add to Collection

Editorial Material Allergy

Lung Function Abnormalities and Their Correlation With Clinical Characteristics and Inflammatory Markers in Adult Asthma

C. Betancor, J. M. Olaguibel, J. M. Rodrigo-Munoz, M. J. Alvarez Puebla, E. Arismendi, P. Barranco, B. Barroso, I Bobolea, B. Cardaba, M. J. Cruz, E. Curto, V Del Pozo, J. Dominguez-Ortega, F. J. Gonzalez-Barcala, J. A. Luna-Porta, C. Martinez-Rivera, J. Mullol, X. Munoz, C. Picado, V Plaza, S. Quirce, M. J. Rial, L. Soto-Retes, A. Valero, M. Valverde-Monge, J. Sastre

JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY (2023)

Add to Collection

Review Allergy

Response to Monoclonal Antibodies in Asthma: Definitions, Potential Reasons for Failure, and Therapeutic Options for Suboptimal Response

Perez L. de Llano, C. Cisneros, J. Dominguez-Ortega, E. Martinez-Moragon, J. M. Olaguibel, V Plaza, S. Quirce, I Davila

Summary: Real-life data show that over 50% of severe asthma patients treated with monoclonal antibodies do not achieve a complete response. The response can be measured qualitatively or quantitatively, and both methods are important for clinical decisions. Various factors contribute to suboptimal response, and a comprehensive evaluation is necessary to guide treatment decisions.

JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY (2023)

Add to Collection

Article Respiratory System

Identification of Asthma Phenotypes in the Spanish MEGA Cohort Study Using Cluster Analysis

Marcos Matabuena, Francisco Javier Salgado, Juan Jose Nieto-Fontarigo, Maria J. Alvarez-Puebla, Ebymar Arismendi, Pilar Barranco, Irina Bobolea, Maria L. Caballero, Jose Antonio Canas, Blanca Cardaba, Maria Jesus Cruz, Elena Curto, Javier Dominguez-Ortega, Juan Alberto Luna, Carlos Martinez-Rivera, Joaquim Mullol, Xavier Munoz, Javier Rodriguez-Garcia, Jose Maria Olaguibel, Cesar Picado, Vicente Plaza, Santiago Quirce, Manuel J. Rial, Christian Romero-Mesones, Beatriz Sastre, Lorena Soto-Retes, Antonio Valero, Marcela Valverde-Monge, Victoria Del Pozo, Joaquin Sastre, Francisco Javier Gonzalez-Barcala

Summary: This study used unsupervised cluster analysis to identify four asthma phenotypes, including adult-onset, adolescent-onset, middle-age-onset, and elderly-onset. These phenotypes differ from each other in terms of lung function, age of onset, BMI, atopy, asthma severity, exacerbations, control, social class, smoking, and nasal polyps.

ARCHIVOS DE BRONCONEUMOLOGIA (2023)

Add to Collection

Article Biochemistry & Molecular Biology

Analysis of Differentially Expressed MicroRNAs in Serum and Lung Tissues from Individuals with Severe Asthma Treated with Oral Glucocorticoids

Marta Gil-Martinez, Clara Lorente-Sorolla, Jose M. Rodrigo-Munoz, Miguel Angel Lendinez, Gonzalo Nunez-Moreno, Lorena de la Fuente, Pablo Minguez, Ignacio Mahillo-Fernandez, Joaquin Sastre, Marcela Valverde-Monge, Santiago Quirce, Maria L. Caballero, Francisco J. Gonzalez-Barcala, Ebymar Arismendi, Irina Bobolea, Antonio Valero, Xavier Munoz, Maria Jesus Cruz, Carlos Martinez-Rivera, Vicente Plaza, Jose M. Olaguibel, Victoria del Pozo

Summary: MicroRNAs (miRNAs) are increasingly being used as biomarkers for diagnosis and treatment of various diseases. This study analyzed miRNA expression profiles in serum and lung tissue from severe asthma patients with and without oral corticosteroids (OCS) treatment. MiRNA-Seq and RT-qPCR were used for evaluation and validation of miRNA levels. Altered expression of miRNAs in serum and lung tissue was observed, with hsa-miR-221-5p and hsa-miR-769-5p showing the best differentiation between OCS-treated and untreated individuals. These miRNAs were found to be associated with important signaling pathways for asthma and regulated the expression of genes involved in these pathways. The findings suggest that miRNA profiles can serve as biomarkers for OCS treatment in asthma patients.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Add to Collection

Letter Respiratory System

The New ERS/ATS 2022 Bronchodilator Response Recommendation: Comparison With the Previous Version in an Asthma Cohort

Diana Betancor, Carlos Villalobos-Vilda, Jose Maria Olaguibel, Jose Manuel Rodrigo-Munoz, Maria Jose Alvarez Puebla, Ebymar Arismendi, Pilar Barranco, Blanca Barroso, Irina Bobolea, Blanca Cardaba, Maria Jesus Cruz, Elena Curto, Victoria Del Pozo, Javier Dominguez-Ortega, Francisco-Javier Gonzalez-Barcala, Juan Alberto Luna-Porta, Carlos Martinez-Rivera, Joaquim Mullol, Xavier Munoz, Cesar Picado, Vicente Plaza, Santiago Quirce, Manuel Jorge Rial, Lorena Soto-Retes, Antonio Valero, Marcela Valverde-Monge, Joaquin Sastre

ARCHIVOS DE BRONCONEUMOLOGIA (2023)

Add to Collection

Meeting Abstract Allergy

Usefulness of Component Resolved Diagnosis in Food induced Anaphylaxis. Review of a series of cases included in the International Registry of Anaphylaxis

Marta Anda, Esozia Arrobarren Aleman, Blanca Garcia, Cristina Pesantez, Maria Jose Zavala, Jose Maria Olaguibel

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2023)

Add to Collection

Meeting Abstract Allergy

Usefulness of Component Resolved Diagnosis in anaphylaxis. Review of a series of cases included in the International Registry of Anaphylaxis.

Esozia Arrobarren Aleman, Blanca Garcia, Marta Anda, Cristina Pesantez, Maria Jose Zavala, Jose Maria Olaguibel

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2023)

Add to Collection

Meeting Abstract Respiratory System

Multi-ancestral meta-analysis yields novel genetic loci for asthma exacerbations

E. Herrera Luis, V. E. Ortega, E. J. Ampleford, Y. Y. Sio, R. Granell, E. De Roos, N. Terzikhan, E. Elorduy Vergara, N. Hernandez-Pacheco, J. Perez-Garcia, E. Martin-Gonzalez, F. Lorenzo-Diaz, S. Hashimoto, P. Brinkman, A. L. Jorgensen, Q. Yan, E. Forno, S. J. Vijverberg, R. Lethem, A. Espuela-Ortiz, M. Gorenjak, C. Eng, R. Gonzalez-Perez, J. M. Hernandez-Perez, P. Poza-Guedes, O. Sardon, P. Corcuera, G. A. Hawkins, A. Marsico, T. Bahmer, K. F. Rabe, G. Hansen, M. Kopp, R. Rios, M. J. Cruz, F. Gonzalez-Barcala, J. M. Olaguibel, V Plaza, S. Quirce, G. Canino, M. Cloutier, V Del Pozo, J. R. Rodriguez-Santana, J. Korta-Murua, J. Villar, U. Potocnik, C. Figueiredo, M. Kabesch, S. Mukhopadhyay, M. Pirmohamed, D. B. Hawcutt, E. Melen, C. N. Palmer, S. Turner, A. H. Maitland-Van der Zee, E. Von Mutius, J. C. Celeclon, G. Brusselle, F. T. Chew, E. Bleecker, D. Meyers, E. G. Burchard, M. Pino-Yanes

EUROPEAN RESPIRATORY JOURNAL (2022)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.